作者: Robert W. Buchanan , William T. Carpenter
DOI: 10.2165/00023210-199605040-00002
关键词: Schizophrenia 、 Intensive care medicine 、 Negative symptom 、 Neurology 、 Antipsychotic 、 Pharmacotherapy 、 Medicine 、 Tardive dyskinesia 、 Psychopharmacology 、 Pharmacology (medical) 、 Psychiatry and Mental health 、 Clinical neurology
摘要: Summary The development of targeted maintenance treatment with anti psychotics arose out the recognition that, despite its efficacy for preventing relapses schizophrenia, standard was associated a number actual and potential disadvantages. Targeted designed to circumvent these disadvantages by decreasing total antipsychotic exposure while maintaining prophylactic benefit treatment. has been shown be effective in reducing may negative symptoms. However, use is an increase relapse hospitalisation rates. These increased rates limit recommended approach selected patient populations.